Ovarian cancer development and metastasis.
Lengyel E.
Am J Pathol. 2010 Sep;177(3):1053-64. doi: 10.2353/ajpath.2010.100105. Epub 2010 Jul 22.
Needleoscopic Conservative Staging of Borderline Ovarian Tumor.
Gueli Alletti S, Rossitto C, Perrone E, Cianci S, De Blasis I, Fagotti A, Scambia G.
J Minim Invasive Gynecol. 2017 May-Jun;24(4):529-530. doi: 10.1016/j.jmig.2016.10.009. Epub 2016 Oct 27.
Endometriosis-associated cancer.
Guidozzi F.
Climacteric. 2021 Dec;24(6):587-592. doi: 10.1080/13697137.2021.1948994. Epub 2021 Jul 16.
Management of borderline ovarian tumours.
Gershenson DM.
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:49-59. doi: 10.1016/j.bpobgyn.2016.09.012. Epub 2016 Oct 3.
A diagnostic challenge of primary serous borderline tumor involving the peritoneum: A case report.
Masoud R, Hamed H, Abdelrazek HM, Emara M, Abdelsalam RA.
Int J Surg Case Rep. 2025 Aug;133:111527. doi: 10.1016/j.ijscr.2025.111527. Epub 2025 Jun 16.
Borderline ovarian tumors.
Link CJ Jr, Reed E, Sarosy G, Kohn EC.
Am J Med. 1996 Aug;101(2):217-25. doi: 10.1016/s0002-9343(96)80079-9.
Borderline ovarian tumours.
Tropé CG, Kaern J, Davidson B.
Best Pract Res Clin Obstet Gynaecol. 2012 Jun;26(3):325-36. doi: 10.1016/j.bpobgyn.2011.12.006. Epub 2012 Feb 7.
Genetic diagnosis of pseudomyxoma peritonei originating from mucinous borderline tumor inside an ovarian teratoma.
Taguchi A, Rokutan H, Oda K, Tanikawa M, Tanimoto S, Sone K, Mori M, Tsuruga T, Kohsaka S, Tatsuno K, Shinozaki-Ushiku A, Miyagawa K, Mano H, Aburatani H, Ushiku T, Osuga Y.
BMC Med Genomics. 2022 Mar 7;15(1):51. doi: 10.1186/s12920-022-01188-x.
[Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers].
Nyangoh-Timoh K, Bendifallah S, Dion L, Ouldamer L, Levêque J.
Gynecol Obstet Fertil Senol. 2020 Mar;48(3):277-286. doi: 10.1016/j.gofs.2020.01.015. Epub 2020 Jan 28.
Psammomacarcinoma of the peritoneum.
Piura B, Rabinovich A, Yanai-Inbar I.
Eur J Obstet Gynecol Reprod Biol. 2001 Aug;97(2):231-4. doi: 10.1016/s0301-2115(00)00508-x.
